HMMJ-U:CA:TSX-Horizons Marijuana Life Sciences Index ETF (USD)

ETF | Others |

Last Closing

CAD 7.6

Change

0.00 (0.00)%

Market Cap

CAD 0.09B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

ETFs Containing HMMJ-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.73% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.73% 66% D+ 63% D
Trailing 12 Months  
Capital Gain 6.29% 47% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.29% 45% F 44% F
Trailing 5 Years  
Capital Gain -44.32% 2% F 12% F
Dividend Return 1.47% 73% C 8% B-
Total Return -42.85% 2% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain 16.78% 97% N/A 85% B
Dividend Return 16.79% 97% N/A 84% B
Total Return 0.01% 11% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 64.14% 3% F 12% F
Risk Adjusted Return 26.17% 60% D- 51% F
Market Capitalization 0.09B 65% D 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.